retatrutide weight loss clinical trials results New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Eli Lilly infiltrates anti-obesity market

Additional Considerations In addition to following a GLP-1-friendly meal plan, there are other factors to keep in mind to ensure success

However, weight loss, especially large amounts in short periods of time, isnt all sunshine

Laboratory Findings That Require Attention You should always talk with your provider about your lab results

Reconstituted: Refrigerate at 28 C (35.646.4 F)

Available from: Accessed June 1, 2025

The dysesthesia side effect Approximately 12.5% of participants on the highest dose of retatrutide experienced dysesthesia, or abnormal skin sensations, including a burning, tingling or pins and needles sensation